Kamila Valieva, the Russian figure skating standout who became the center of an international anti-doping controversy at the 2022 Winter Olympics, was just 15 years old when laboratory results revealed she had tested positive for a banned heart medication two months prior to the Games.
The Positive Test and the Beijing Olympics
Kamila Valieva tested positive for trimetazidine, a substance commonly prescribed to treat angina, according to a statement released by the International Testing Agency (ITA) on Friday, February 10, 2022. The banned sample had been collected weeks earlier on December 25, 2021, at the Russian Figure Skating Championships in Saint Petersburg by the Russian Anti-Doping Agency (RUSADA). However, the analytical result did not emerge from the World Anti-Doping Agency-accredited laboratory in Stockholm, Sweden, until February 8, 2022—one day after Valieva helped the Russian Olympic Committee (ROC) secure the gold medal in the team figure skating event in Beijing. The delayed notification triggered an immediate crisis, halting the medal ceremony for the team competition, which also involved silver medalist Team USA and bronze medalist Team Japan. The ITA noted that because trimetazidine is classified as a hormone and metabolic modulator, it is prohibited by the World Anti-Doping Agency (WADA) due to evidence indicating it can improve endurance and increase blood flow.
Legal Battles Over Provisional Suspension
Following the laboratory notification, RUSADA imposed an immediate provisional suspension on Valieva, barring her from competition. The skater successfully challenged the sanction during a hearing on February 9, 2022, prompting the Russian anti-doping body to lift the ban and allow her to continue skating at the Winter Games, according to the ITA. That reinstatement prompted an immediate legal challenge. The International Olympic Committee (IOC) announced it would challenge RUSADA’s decision to lift the provisional suspension before the Court of Arbitration for Sport (CAS). The case required an expedited ruling ahead of Valieva’s scheduled appearance in the women’s singles short program competition on Tuesday, where she entered as the heavy favorite for gold. “The decision on the results of the ROC team in the Team Figure Skating event can be taken … only after a final decision on the full merits of the case has been taken,” the ITA stated regarding the withheld medals.
Responses and Protected Person Status
Because Valieva was 15 at the time of the controversy, she qualified as a “Protected Person” under the World Anti-Doping Code, a designation that shields minors from mandatory public disclosure of their identities during doping proceedings. The ITA stated it officially released her name only after media reports published her identity based on unofficial information, acknowledging the necessity of transparency amid intense global public interest. The Russian Olympic Committee defended the athlete, stating that Valieva had repeatedly passed mandatory doping controls both before and after the December sample was taken, including tests administered while she was in Beijing. “The doping test of an athlete who tested positive does not apply to the period of the Olympic Games,” the ROC said in a public statement, adding that the organization was taking comprehensive measures to protect the skater’s rights and preserve her “honestly won” gold medal. IOC spokesperson Mark Adams told journalists on Friday that the governing body was working to expedite the legal proceedings as the case moved toward the Court of Arbitration for Sport.
